Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991341 · ClinicalTrials.gov registry record · Phase 3
Red Cell Storage Duration Study
A Phase 3 study, sponsored by Carelon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,481
- Enrollment target
NCT00991341 is a Phase 3 study that has completed, run by Carelon Research. The registered enrollment target is 1,481 participants.
The verdict
NCT00991341, a Phase 3 study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,481 participants
- Enrollment target
Study Summary
The RECESS study will compare the effects of transfusing red blood cell units stored \<= 10 days vs. red blood cell units stored \>= 21 days, in patients who are undergoing complex cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis is that there is a clinically important difference between the effects of shorter-storage red cell units and longer-storage red cell units on clinical outcomes and mortality risk.
Interventions
- BIOLOGICAL Red blood cell units stored <= 10 days
- BIOLOGICAL Red blood cell units stored >= 21 days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,481 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991341
The ClinicalTrials.gov registry entry for NCT00991341 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,481 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Red blood cell units stored <= 10 days is the first listed.
NCT00991341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991341 about?
NCT00991341 is a clinical study titled "Red Cell Storage Duration Study". The RECESS study will compare the effects of transfusing red blood cell units stored \<= 10 days vs. red blood cell units stored \>= 21 days, in patients who are undergoing complex cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis is that there is a clinical...
What is the current status of trial NCT00991341?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,481 participants. The study started on 2010-01. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00991341?
The interventions under investigation include: Red blood cell units stored <= 10 days (BIOLOGICAL), Red blood cell units stored >= 21 days (BIOLOGICAL).
Who is sponsoring clinical trial NCT00991341?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.